Lee Ann Garrett-Sinha, PhD, associate professor of biochemistry, has been named an associate editor of The Journal of Immunology.


Award-winning participants in the Department of Medicine’s second annual Research Day are studying diverse topics, including disease processes for atrial fibrillation; treatments for leukemia, diabetes and COPD; and the need for cortisol.


Ira Jacob Blader, PhD, associate professor of microbiology and immunology, will build on prior research to identify and explore a key host cell pathway essential for the growth of the infection-causing parasite Toxoplasma gondii.

University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).

University at Buffalo experiments from a day care center have revealed that two common bacteria persist on various surfaces for extended periods of time.


With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.


With a focus on the Escherichia coli bacterium, Mark Sutton, PhD, associate professor of biochemistry, will build on a decade of research to further study the complex coordination of molecular mechanisms that contribute to mutations in DNA replication and repair.


Through her fledgling start-up firm, University at Buffalo researcher Kate Rittenhouse-Olson, PhD ’84, is turning a mouse antibody she created into a promising cancer-fighting therapy for humans.

A University at Buffalo study has revealed how Streptococcus pneumoniae—bacteria that harmlessly colonize the mucous linings of human throats and noses—become virulent when they travel to the middle ears, lungs or bloodstream.

Researchers in the Department of Microbiology and Immunology have developed a new way to stimulate an immune response to gonorrhea.


More than 100 student scientists from across the country showcased their original research during this summer’s University at Buffalo Biomedical Research Day.

Piero R. Bianco, PhD, associate professor of microbiology and immunology, will use a $1.8 million grant to develop the first clear model of a biochemical DNA repair mechanism needed to stave off cancer.

Richard B. Bankert, VMD, PhD, professor in the Department of Microbiology and Immunology, and Zhen Yan, PhD, professor in the Department of Physiology and Biophysics, have received 2013 SUNY Chancellor’s Awards for Excellence.


The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.


Virginia Havel, a PhD student in microbiology and immunology, has received an American Heart Association Founders Affiliate predoctoral fellowship.


Researchers have discovered a new vaccine target for tuberculosis using a UB-patented adjuvant that boosts the potency of mucosal vaccines.


Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.


UB researchers have identified specific roles for two innate immune pathways that drive acute lung injury—findings that may lead to the first treatment or preventive strategy for the condition.


UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.


Kate Rittenhouse-Olson, PhD, professor of biotechnical and clinical laboratory sciences, and Ernesto De Nardin, PhD, adjunct professor of microbiology and immunology, have co-authored a clinical immunology textbook.